Search
Now showing items 1-5 of 5
Out of range laboratory values: a major reason for exclusion from a phase 1 HIV vaccine clinical trial
(University of Nairobi, 2006)
Safety and immunogenicity of DNA and MVA HIVA vaccines in Phase-1 vaccine trials in Nairobi, Kenya
(University of Nairobi, 2004)
Safety profile of DNA and MVA HIV preventive vaccines
(University of Nairobi, 2004)
Challenges experienced by the clinical team during the conduct of HIV vaccine clinical trials in Kenya
(University of Nairobi, 2005)